Mark Bouw Group Pty Ltd

What Mark Bouw Group Pty Ltd does

Straterra Australia Pty Ltd (trading as Straterra, and referenced in the query as Mark Bouw Group Pty Ltd) is a Melbourne-based professional services firm specialising in enterprise value optimisation for transaction-focused MedTech, Digital Health, and Life Sciences businesses. The firm was founded in 2010 and operates with a small team of 8 employees under ABN 70 628 272 104, holding Registered Tax Agent status (TPB#26102079). It targets post-seed startups facing funding milestone pressure and mid-market businesses preparing for capital raises, partial sales, strategic acquisitions, or exits, as well as international companies onshoring R&D into Australia.

The firm delivers five core service offerings structured around a proprietary five-driver valuation framework: Valuation Readiness Assessment, Cash Runway Extension, Value Creation Retainer, Transaction Preparation (comprising Series A Preparation and Sale and Exit Readiness), and Australian R&D Operations. These services are applied across three sector verticals — MedTech, Digital Health, and Life Sciences — with each sector having specific value drivers related to clinical, regulatory, IP, reimbursement, and capital milestones. Underlying delivery is based on senior consulting expertise rather than proprietary technology or software platforms.

Revenue is generated through professional services engagements on a project and retainer basis, with pricing handled through confidential mandate discussions rather than standardised tiers. The go-to-market is sales-led and direct, with content marketing via the company's website as the primary top-of-funnel channel. Reported cumulative client outcomes include USD $443M+ in combined exit value delivered across three major exits and AUD $200M+ in cashflow and operating resilience delivered via Australian R&D Tax Incentive optimisation.

Name

Mark Bouw Group Pty Ltd

Legal name

Straterra Australia Pty Ltd

Website

https://markbouw.com.au

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Straterra Australia Pty Ltd is a Melbourne-based boutique advisory firm that provides valuation optimisation, transaction readiness, and Australian R&D operating services to post-seed startups and mid-market MedTech, Digital Health, and Life Sciences businesses preparing for capital events or exits.

Ownership category

akta.pro rank

Product category

Management Consulting / Valuation Advisory

NAICS

Management Consulting Services (54161), Accounting, Tax Preparation, Bookkeeping, and Payroll Services (54121)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Operations & Process Improvement Consulting (BPAHACAB)

Keywords

• Valuation optimization services
• Transaction readiness consulting
• Operating partner advisory
• R&D tax incentive
• Life sciences advisory

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Strategic Operating Partner Services: Revenue generated through professional services engagements including Valuation Readiness Assessment, Cash Runway Extension, Value Creation Retainer, Transaction Preparation, and Australian R&D Operations services. The model is primarily project-based and retainer-based for ongoing operating partner engagements, targeting transaction-focused businesses.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Straterra delivers specialist operating-partner professional services that identify and implement value-uplift improvements for transaction-focused MedTech, Digital Health, and Life Sciences businesses. Core capabilities include Valuation Readiness Assessment, Cash Runway Extension, Value Creation Retainer, Transaction Preparation (Series A Preparation and Sale/Exit Readiness), and Australian R&D Operations for international companies onshoring R&D into Australia. Engagements are delivered on a confidential, mandate-driven basis using a proprietary five-driver valuation framework.

Product overview

Straterra is a specialist operating partner offering a unified suite of transaction-focused professional services for MedTech, Digital Health, and Life Sciences businesses. The portfolio consists of five core service offerings: Valuation Readiness Assessment (identifies value-constraining drivers), Cash Runway Extension (improves cash visibility and R&D incentives), Value Creation Retainer (senior operating support for value-uplift execution), Transaction Preparation (comprising Series A Preparation and Sale/Exit Readiness pathways), and Australian R&D Operations (establishes R&D structure for international companies). These services are delivered across three sector verticals—MedTech, Digital Health, and Life Sciences—each with sector-specific drivers and evidence requirements. The offering is a consulting/services model rather than a software platform, focused on pre-transaction readiness, valuation optimization, and exit preparation.

Differentiator

Problem solved

Functional benefit

Products and services

• Valuation Readiness Assessment Identifies the drivers constraining enterprise value and prioritises the improvements that matter before a capital raise, sale, exit, or strategic review. Best suited for optimising pre-transaction activities. For transaction-focused MedTech, Digital Health, and Life Sciences businesses.
• Cash Runway Extension Improves cash visibility, cost discipline, R&D incentive pathways, and runway resilience before the next value event. Best suited for closing the runway-to-value-event gap. For MedTech, Digital Health, and Life Sciences businesses approaching a transaction or funding milestone.
• Value Creation Retainer Embeds senior operating support to implement priority value-uplift actions and track progress against investor-grade measures. Best suited for executing pre-transaction activities on an ongoing retainer basis. For MedTech, Digital Health, and Life Sciences business leaders.
• Transaction Preparation Prepares businesses for capital, sale, or exit through two pathways: Series A Preparation and Sale and Exit Readiness. Best suited for preparing a defined transaction event. Includes transaction-ready pathway design, due diligence readiness, and enterprise value positioning. For MedTech, Digital Health, and Life Sciences businesses approaching a transaction event.
• Australian R&D Operations Establishes Australian R&D operations to access onshore capability, incentive access, and compliance discipline. Best suited for international businesses seeking optimised R&D tax efficiency. Delivered under Straterra's Registered Tax Agent status (TPB#26102079).
• MedTech Sector Services Strategic operating support for MedTech businesses, addressing the clinical, regulatory, IP, and capital milestones that determine transaction valuation. Prioritises governance, evidence, and operating work required for transaction readiness. For MedTech business leaders.
• Digital Health Sector Services Strategic operating support for Digital Health businesses, focusing on revenue quality, reimbursement logic, deployment scalability, and data defensibility to build clearer investor or acquirer narratives. For Digital Health business leaders.
• Life Sciences Sector Services Strategic operating support for Life Sciences businesses, emphasising defensible evidence, repeatable demand, channel quality, and resilient margins to support durable enterprise value. For Life Sciences business leaders.

Quantifiable outcome

• USD $443M+ combined exit value delivered
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• LEK Consulting: Global strategy consulting firm with a deep healthcare and life sciences practice advising on transaction due diligence, commercial strategy, and value creation — broader incumbent with overlapping healthcare transaction advisory capability.
• Simon-Kucher & Partners: Global consulting firm with a healthcare and life sciences practice focused on pricing, reimbursement, and commercial strategy — overlapping with Straterra's Digital Health reimbursement and Life Sciences margin/durability work.
• Charles River Associates: Global consulting firm with a Life Sciences practice providing commercial diligence, litigation support, and strategic advisory for healthcare transactions — a broader incumbent playing in adjacent healthcare strategy work.

Direct peers

• Trinity Life Sciences: Life sciences commercial strategy firm delivering evidence-based consulting to pharma, biotech, and MedTech clients on commercial readiness and transaction-related work — comparable to Straterra's commercial/operational readiness engagements.
• Health Advances: Specialist strategy consulting firm focused exclusively on healthcare and life sciences, advising on transaction due diligence, commercial assessment, and portfolio strategy — closely aligned with Straterra's MedTech/Digital Health/Life Sciences mandate profile.
• ClearView Healthcare Partners: Boutique life sciences strategy consulting firm supporting biopharma and MedTech companies on transaction-related diligence, commercial strategy, and value-creation work — directly comparable to Straterra's transaction-readiness focus for healthcare innovators.
• Locust Walk: Life sciences transaction advisory firm supporting biopharma and MedTech companies on financings, M&A, and strategic transactions — directly comparable to Straterra's transaction-preparation service line.
• Back Bay Life Science Advisors: Boutique life sciences advisory firm providing strategic and transactional advisory to growth-stage MedTech, Digital Health, and Life Sciences companies — a direct comparable on both sector focus and transaction-readiness positioning.

Regional players

• RSM Australia: Australia-based professional services firm with an R&D Tax Incentive practice advising on R&D tax claims and compliance — directly comparable to Straterra's Australian R&D Operations offering and a likely collaborator or competitor for international onshoring clients.
• Pitcher Partners: Australian mid-market accounting and advisory firm with R&D tax incentive and transaction advisory services — a regional peer competing for the same Australian mid-market MedTech/Life Sciences transaction-preparation mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/markbouwgroup

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mark Bouw Group Pty Ltd